- Report
- October 2024
- 197 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 173 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- July 2024
- 144 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- May 2024
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- March 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- February 2024
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- December 2023
- 172 Pages
Global
€4767EUR$4,995USD£3,994GBP
- Report
- October 2024
- 100 Pages
Global
From €3500EUR$3,929USD£3,035GBP
The Arbovirus Testing market is a subset of the larger Infectious Disease Testing market. It is focused on the detection of arboviruses, which are a group of viruses transmitted by arthropods such as mosquitoes, ticks, and sandflies. These viruses can cause a range of illnesses, including dengue, chikungunya, Zika, and yellow fever. Arbovirus Testing is used to diagnose and monitor these diseases, as well as to track the spread of arboviruses in a given population.
Arbovirus Testing is typically performed using molecular techniques such as PCR and RT-PCR, as well as serological methods such as ELISA and immunofluorescence. These tests are available from a variety of companies, including Abbott, Bio-Rad, Cepheid, DiaSorin, Hologic, and Roche. Show Less Read more